TICKERNOMICS Sign up
Last Update: 2023-12-23 05:59:03
Prestige Consumer Healthcare Inc. ( PBH ) https://www.prestigebrands.com
61.69USD
Sector:
Healthcare
Industry:
Drug Manufacturers-Specialty & Generic
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
PBH
0.23%
SPY
30.72%
PBH
78.84%
SPY
112.82%
PBH
114.84%
SPY
201.04%
PBH
83.42%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
3089.50
4318.48
0.16
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-37.78
2.74
2.01
7.26
0.77
11.47
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
30.82
55.89
33.41
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
6.137
8.44
9.88
0.55
Other Earnings and Cash Flow Stats:
Prestige Consumer Healthcare Inc. ( PBH ) Net Income TTM ($MM) is -84.02
Prestige Consumer Healthcare Inc. ( PBH ) Operating Income TTM ($MM) is 349.49
Prestige Consumer Healthcare Inc. ( PBH ) Owners' Earnings Annual ($MM) is 0.00
Prestige Consumer Healthcare Inc. ( PBH ) Current Price to Owners' Earnings ratio is 0.00
Prestige Consumer Healthcare Inc. ( PBH ) EBITDA TTM ($MM) is 375.59
Prestige Consumer Healthcare Inc. ( PBH ) EBITDA Margin is 33.41%
Capital Allocation:
Prestige Consumer Healthcare Inc. ( PBH ) has paid 0.47 dividends per share and bought back 0.184 million shares in the past 12 months
Prestige Consumer Healthcare Inc. ( PBH ) has reduced its debt by 184.047 million USD in the last 12 months
Capital Structure:
Prestige Consumer Healthcare Inc. ( PBH ) Interest-bearing Debt ($MM) as of last quarter is 1289
Prestige Consumer Healthcare Inc. ( PBH ) Annual Working Capital Investments ($MM) are -42
Prestige Consumer Healthcare Inc. ( PBH ) Book Value ($MM) as of last quarter is 1535
Prestige Consumer Healthcare Inc. ( PBH ) Debt/Capital as of last quarter is 83%
Other Balance Sheet Stats:
Prestige Consumer Healthcare Inc. ( PBH ) has 60 million in cash on hand as of last quarter
Prestige Consumer Healthcare Inc. ( PBH ) has 129 million of liabilities due within 12 months, and long term debt 1262 as of last quarter
Prestige Consumer Healthcare Inc. ( PBH ) has 50 common shares outstanding as of last quarter
Prestige Consumer Healthcare Inc. ( PBH ) has 0 million USD of preferred stock value
Academic Scores:
Prestige Consumer Healthcare Inc. ( PBH ) Altman Z-Score is 2.33 as of last quarter
Prestige Consumer Healthcare Inc. ( PBH ) Piotroski Score is 8.00 as of last quarter
Corporate Governance:
Prestige Consumer Healthcare Inc. ( PBH ) largest shareholder is Allspring Global Investments Holdings, LLC owning 1087821 shares at 67.11 ($MM) value
Mary Beth Fritz(an insider) Sold 2540 shares of Prestige Consumer Healthcare Inc. ( PBH ) for the amount of $149656.80 on 2023-09-14
1.19% of Prestige Consumer Healthcare Inc. ( PBH ) is held by insiders, and 104.31% is held by institutions
Prestige Consumer Healthcare Inc. ( PBH ) went public on 2005-02-10
Other Prestige Consumer Healthcare Inc. ( PBH ) financial metrics:
FCF:223.50
Unlevered Free Cash Flow:0.00
EPS:4.28
Operating Margin:30.82
Gross Profit Margin:55.89
Div. Payout Ratio%:-29.09
Div. Growth YoY%:0.00
Equity Return%:13.95
Beta:0.55
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Prestige Consumer Healthcare Inc. ( PBH ) :
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.